GRCE — Grace Therapeutics Share News
0.000.00%
Last trade - 00:00U.S. STOCKS ON THE MOVE-Meta Platforms, Tesla, Coty
U.S. STOCKS ON THE MOVE-NuZee, AAON, Gold miners
Acasti Pharma falls on 1-for-6 reverse stock split
Brief: Acasti Pharma Announces 1-For-6 Reverse Stock Split
U.S. STOCKS ON THE MOVE-Rivian, Alphabet, Moderna
Acasti Pharma jumps on late-stage trial plans for lead drug
Acasti Pharma Inc reports results for the quarter ended in March - Earnings Summary
Brief: Acasti Announces Appointment Of New Scientific Advisory Board Members
Acasti Pharma Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Acasti Submits Pivotal Gtx-104 Phase 3 Safety Study Protocol With FDA
Acasti gets regulatory pathway for drug, names new CEO; shares rise
Acasti Pharma rises on positive data for genetic disorder drug
Diagnostics, Williams-Sonoma, Cytokinetics
U.S. STOCKS ON THE MOVE-Vaccine makers, SeaChange, Voya Financial, BiondVax
U.S. STOCKS ON THE MOVE-Reliance Global, Allakos, Acasti Pharma, CalAmp Corp
Oppenheimer bullish on Acasti's pipeline after Grace Therapeutics buyout
U.S. STOCKS ON THE MOVE-Omeros, CF Acquisition, Chemomab, Phunware
Acasti Pharma jumps as brain bleed drug shows promise
Acasti Pharma: Plunges after blood disorder drug fails to meet main goal in study